Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Stock Options - Activity (Details)

v3.21.1
Stockholders' Equity - Stock Options - Activity (Details) - $ / shares
12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Shares    
Outstanding at the beginning of the period (in shares) 11,249  
Granted (in shares) 0 0
Forfeited, cancelled or expired (in shares) (2,325)  
Outstanding at the end of the period (in shares) 8,924 11,249
Weighted Average Exercise Price    
Outstanding at the beginning of the period (in dollars per share) $ 215.56  
Forfeited, cancelled or expired (in dollars per share) 204.97  
Outstanding at the end of the period (in dollars per share) $ 218.32 $ 215.56
Fully vested and expected to vest    
Shares (in shares) 8,924  
Weighted average exercise price (in dollars per share) $ 218.32  
Weighted average remaining contractual term 1 year 7 months 6 days  
Additional disclosures    
Weighted average remaining contractual term, options outstanding 1 year 7 months 6 days  
Shares, options exercisable (in shares) 8,924  
Weighted average exercise price, options exercisable (in dollars per share) $ 218.32  
Weighted average remaining contractual term, options exercisable 1 year 7 months 6 days